AMGEN INC (AMGN)
Clinical trial NCT07313761 updates: 1. completion date: 2026-06-26 → 2026-07-02 2. primary completion date: 2026-06-26 → 2026-07-02
Clinical trial NCT07313761 updates: 1. completion date: 2026-06-26 → 2026-07-02 2. primary completion date: 2026-06-26 → 2026-07-02
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical